Oral anticoagulants in atrial fibrillation: educational visit

Oral Anticoagulants interactive small group learning for clinicians (2 or more participants)

Atrial fibrillation (AF) is the most common heart arrhythmia in Australia, with a significant impact on morbidity and mortality. AF-related strokes are 2.5 times more likely to be fatal, making early detection and optimal anticoagulation therapy critical for reducing risk. Despite advances in treatment, challenges remain in identifying high-risk patients, initiating and monitoring anticoagulants, and supporting adherence to treatment and lifestyle modifications.

This interactive course equips health professionals with the latest evidence-based approaches to AF screening, risk stratification, and anticoagulation management. Through clinical case discussions and practical strategies, participants will enhance their ability to identify, assess, and manage AF in primary care and hospital settings. The course also highlights the importance of shared decision-making and patient-centred communication in optimising long-term outcomes.

Key Learning Outcomes:

• Identify patients at high risk of AF and apply evidence-based screening measures.

• Assess the risks and benefits of anticoagulation therapy, considering individual patient factors.

• Optimise treatment outcomes by implementing effective monitoring and review protocols.

• Develop comprehensive management plans incorporating lifestyle modifications to reduce stroke risk.

By attending, you’ll gain the knowledge and skills to improve opportunistic screening, initiate anticoagulation appropriately, and enhance patient adherence—helping to reduce the burden of AF-related strokes in Australia.

 This educational session is brought to you by Medcast and the Quality Use of Medicines Alliance. 

For more free Quality Use of Medicines education, check out QHUB on Medcast